- Trials with a EudraCT protocol (75)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
75 result(s) found for: Transcriptome.
Displaying page 1 of 4.
EudraCT Number: 2022-003879-42 | Sponsor Protocol Number: 2021/ABM/03/00006 | Start Date*: 2023-04-12 | ||||||||||||||||
Sponsor Name:Medical Univeristy of Bialystok | ||||||||||||||||||
Full Title: A randomized, controlled, double-blind clinical trial evaluating the effect of METformin treatment on endometrial function in women diagnosed with Idiopathic Infertility | ||||||||||||||||||
Medical condition: Potential causes of idiopathic infertility include in particular: abnormal function of the endometrium, including implantation disorders and immunological abnormalities, genetic abnormalities and t... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: PL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003916-10 | Sponsor Protocol Number: GR-2021-12372898 | Start Date*: 2023-04-21 | ||||||||||||||||
Sponsor Name:OSPEDALE SAN RAFFAELE | ||||||||||||||||||
Full Title: Deciphering B and T cell Co-stimulation for the Targeted Treatment of IgG4-Related Disease | ||||||||||||||||||
Medical condition: IgG4-related disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-004078-53 | Sponsor Protocol Number: 83403 | Start Date*: 2023-08-22 |
Sponsor Name:Academic Medical Center (AMC), department of Internal Medicine | ||
Full Title: Specifying the anti-inflammatory effects of ziltivekimab with diverse imaging modalities and in-depth cellular phenotyping | ||
Medical condition: - Plaque characteristics - Systemic inflammation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001375-32 | Sponsor Protocol Number: PreToVid | Start Date*: 2020-04-03 |
Sponsor Name:UMCG | ||
Full Title: Pre-emptive tocilizumab in hypoxic COVID-19 patients, a prospective randomized trial | ||
Medical condition: Hypoxia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-004930-27 | Sponsor Protocol Number: MTOR-INHIBITION-SARCOIDOSIS | Start Date*: 2019-02-05 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Systems medicine analysis of sarcoidosis by targeting mTOR in a pilot study of sirolimus as treatment in patients with sarcoidosis | ||
Medical condition: Sarcoidosis with cutaneous affections | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-005793-10 | Sponsor Protocol Number: 01012121 | Start Date*: 2021-07-08 | |||||||||||
Sponsor Name:Jakob Benedict Seidelin | |||||||||||||
Full Title: Open label Randomized Controlled clinical Trial of vedolizumab versus conventional treatment for Checkpoint Inhibitor induced Colitis | |||||||||||||
Medical condition: Immune check point inhibitor induced colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002310-16 | Sponsor Protocol Number: LHinPOR001 | Start Date*: 2023-02-01 |
Sponsor Name:UZ Brussel | ||
Full Title: Endometrial gene expression profiles during ovarian stimulation with recombinant human FSH with or without the addition of recombinant human LH in genuine poor responders. | ||
Medical condition: Infertility | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003078-24 | Sponsor Protocol Number: R668-EE-1877 | Start Date*: 2020-09-01 | ||||||||||||||||
Sponsor Name:Regeneron Pharmaceuticals | ||||||||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis | ||||||||||||||||||
Medical condition: Eosinophilic Esophagitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003041-14 | Sponsor Protocol Number: 565 | Start Date*: 2005-09-20 |
Sponsor Name:Department of Clinical Pharmacology, Medical University of Vienna | ||
Full Title: Anti-inflammatory effect of statins in the human endotoxin model | ||
Medical condition: Healthy volunteers are tested in an endotoxemia model | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004406-25 | Sponsor Protocol Number: FCM-RHEUMA-001 | Start Date*: 2014-09-19 | |||||||||||
Sponsor Name:Faculdade de Ciências Médicas da Universidade Nova de Lisboa | |||||||||||||
Full Title: Biomarkers identification of anti-TNF α agent’s efficacy in Ankylosing Spondylitis patients using a transcriptome analysis and mass spectrometry | |||||||||||||
Medical condition: Ankylosing Spondylitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003760-27 | Sponsor Protocol Number: INCENTIVE-QIV-3-EU | Start Date*: 2021-09-21 |
Sponsor Name:Université Libre de Bruxelles | ||
Full Title: INCENTIVE-QIV-3-EU: Immunogenicity, molecular profiling of a marketed quadrivalent influenza vaccine (Vaxigrip Tetra®) administered by the intramuscular route in participants aged 6 to 8 months | ||
Medical condition: Prophylaxis of Influenza (Northern Hemispher 2021-2022 and 2022-2023 season) in Children aged 6-8 months | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001561-32 | Sponsor Protocol Number: 201900237 | Start Date*: 2020-04-28 | ||||||||||||||||
Sponsor Name:University Medical Center Groningen | ||||||||||||||||||
Full Title: Dupilumab in adults with severe chronic hand eczema with an inadequate response or intolerance to alitretinoin: a randomized, double-blind, placebo-controlled proof of concept efficacy study | ||||||||||||||||||
Medical condition: Hand eczema | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019441-26 | Sponsor Protocol Number: P081210 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Adalimumab dans l’Arthrite Juvénile Idiopathique pour le traitement de l’UVéITE (étude ADJUVITE) | |||||||||||||
Medical condition: Uvéite dans l'arthrite Juvénile Idiopathique | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003671-60 | Sponsor Protocol Number: NO-CUT | Start Date*: 2018-04-23 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA AO OSPEDALE NIGUARDA CA' GRANDA | |||||||||||||
Full Title: TOTAL NEOADJUVANT TREATMENT WITHOUT SURGERY FOR LOCALLY ADVANCED RECTAL CANCER: PROSPECTIVE CLINICAL TRIAL TO ASSESS TUMOR COMPLETE RESPONSE, CIRCULATING TUMOR GENETIC AND EPIGENETIC BIOMARKERS, AN... | |||||||||||||
Medical condition: Adenocarcinoma of the medium/lower rectum in Stage II (cT3-4 N0) or Stage III (cT1-4, N1-2) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002854-19 | Sponsor Protocol Number: S58827 | Start Date*: 2017-08-03 |
Sponsor Name:UZ Leuven | ||
Full Title: Neoadjuvant degarelix +/- apalutamide (ARN-509) followed by radical prostatectomy for intermediate and high-risk prostate cancer: a randomized, placebo-controlled trial. | ||
Medical condition: Prostate cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004941-94 | Sponsor Protocol Number: ARC004 | Start Date*: 2017-05-05 |
Sponsor Name:Aimmune Therapeutics, Inc. | ||
Full Title: PEANUT ALLERGY ORAL IMMUNOTHERAPY STUDY OF AR101 FOR DESENSITIZATION IN CHILDREN AND ADULTS (PALISADE) FOLLOW-ON STUDY | ||
Medical condition: Peanut Allergy | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: IE (Completed) GB (Completed) SE (Completed) DE (Completed) ES (Completed) NL (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004358-32 | Sponsor Protocol Number: IJB–TNBC–1–RHEA | Start Date*: 2015-05-07 | |||||||||||
Sponsor Name:Institut Jules Bordet | |||||||||||||
Full Title: Biomarker Research Study for PF-03084014 in cHEmoresistant triple negative breast cAncer - “RHEA” study | |||||||||||||
Medical condition: patients with chemoresistant, triple-negative breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002988-25 | Sponsor Protocol Number: ML-DS2018 | Start Date*: Information not available in EudraCT |
Sponsor Name:Gesellschaft für Pädiatrische Onkologie & Hämatologie (GPOH gGmbH) | ||
Full Title: Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018 | ||
Medical condition: Myeloid Leukemia in Children with Down Syndrome | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Ongoing) NL (Ongoing) AT (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001053-18 | Sponsor Protocol Number: IC 2007-04 | Start Date*: 2008-05-29 |
Sponsor Name:INSTITUT CURIE | ||
Full Title: Étude de phase II randomisée évaluant une irradiation pelvienne associée au Cisplatine seul ou au Cisplatine plus Cetuximab chez des patientes présentant un carcinome du col utérin de stade IB2, II... | ||
Medical condition: Patientes présentant un cancer du col de l’utérus de type épidermoïde ou adénocarcinome de stade Ib2 à IIIb, non antérieurement traitées. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004538-14 | Sponsor Protocol Number: TACTOR-2013 | Start Date*: 2014-07-30 |
Sponsor Name:Azienda Ospedaliera Universitaria Integrata Verona | ||
Full Title: Identification of a specific systemic transcriptome able to differentiate patients with renal transplantation in chronic treatment with tacrolimus from those with mTOR inhibitors. | ||
Medical condition: Renal Transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.